Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riociguat in respiratory disease with hypoxia
2014-001008-23Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of riociguat in pulmonary hypertension due to lung disease (PH) and airway morbidity, sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoints: Change in oxygen saturation, Change in mean pulmonary artery pressure and 2 more. Started Aug 2014; status: completed.
02
Drugs
riociguat
03
Conditions
pulmonary hypertension due to lung disease (PH)airway morbidity
Beyond the preview
Go deeper on 2014-001008-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001008-23.